LRRK2 and Parkinson disease: However, whether LRRK2 inhibitors affect the normal physiology of peripheral tissues, especially the liver, awaits further elucidation, despite that LRRK2 kinase inhibitors can effectively improve the clinical symptoms of PD patients by inhibiting kinase activity.